1. Home
  2. KYTX vs CSBR Comparison

KYTX vs CSBR Comparison

Compare KYTX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • CSBR
  • Stock Information
  • Founded
  • KYTX 2018
  • CSBR 1985
  • Country
  • KYTX United States
  • CSBR United States
  • Employees
  • KYTX N/A
  • CSBR N/A
  • Industry
  • KYTX
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KYTX
  • CSBR Health Care
  • Exchange
  • KYTX NYSE
  • CSBR Nasdaq
  • Market Cap
  • KYTX 125.2M
  • CSBR 135.5M
  • IPO Year
  • KYTX 2024
  • CSBR 1986
  • Fundamental
  • Price
  • KYTX $1.98
  • CSBR $8.61
  • Analyst Decision
  • KYTX Buy
  • CSBR Strong Buy
  • Analyst Count
  • KYTX 5
  • CSBR 1
  • Target Price
  • KYTX $19.20
  • CSBR $12.00
  • AVG Volume (30 Days)
  • KYTX 307.6K
  • CSBR 44.2K
  • Earning Date
  • KYTX 05-13-2025
  • CSBR 03-11-2025
  • Dividend Yield
  • KYTX N/A
  • CSBR N/A
  • EPS Growth
  • KYTX N/A
  • CSBR N/A
  • EPS
  • KYTX N/A
  • CSBR 0.46
  • Revenue
  • KYTX N/A
  • CSBR $58,591,000.00
  • Revenue This Year
  • KYTX N/A
  • CSBR $14.19
  • Revenue Next Year
  • KYTX N/A
  • CSBR $10.11
  • P/E Ratio
  • KYTX N/A
  • CSBR $18.82
  • Revenue Growth
  • KYTX N/A
  • CSBR 19.03
  • 52 Week Low
  • KYTX $1.89
  • CSBR $3.60
  • 52 Week High
  • KYTX $24.91
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 30.38
  • CSBR 39.31
  • Support Level
  • KYTX $2.20
  • CSBR $9.21
  • Resistance Level
  • KYTX $2.57
  • CSBR $9.97
  • Average True Range (ATR)
  • KYTX 0.20
  • CSBR 0.65
  • MACD
  • KYTX -0.03
  • CSBR -0.10
  • Stochastic Oscillator
  • KYTX 11.84
  • CSBR 15.74

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: